A. John Murray Ph.D.
John focuses his practice on patent preparation and prosecution with a technical concentration in the areas of medical devices (including implantable and drug-eluting devices), pharmaceuticals (including active ingredients, formulations and methods of use), drug delivery systems (including gene therapy and nanoparticle drug delivery), diagnostic test methods (including immunodiagnostics and nucleic acid diagnostics), biosensors and humanized antibodies.  He has successfully prosecuted numerous patent applications in the U.S. Patent and Trademark Office and has worked with associates in many other countries to obtain patent protection outside the United States.

John’s counseling experience includes rendering client-requested opinions on patentability, patent validity, patent infringement, and freedom-to-operate. He has also provided counseling in the areas of patent licensing, patent portfolio management and patent term extension.

Prior to studying the law, John worked as a research scientist and project manager in the United States and Europe.  During this time, he was involved in the development of immunodiagnostic test methods and instrumentation. 

Practice Groups
  • J.D., with High Honors
    Illinois Institute of Technology, Chicago-Kent College of Law, 1999
  • Ph.D., Medical Biophysics
    University of Manchester
  • B.S., Physics
    University of Manchester
Bar Admissions
  • Illinois
  • U.S. Dist. Court, N.D. Illinois
  • U.S. Patent & Trademark Office
Technical Background
  • Biopharma
Experience | Legal
Brinks Gilson & Lione, Chicago, Illinois
Forward Thinking
May 23, 2017

On May 22, 2017, the Supreme Court of the United States issued a decision in TC Heartland LLC v. Kraft Foods Group Brands LLC (Case No. 16-341) altering the landscape of venue for patent infringement litigation...

March 18, 2016

Prior to the implementation of the Leahy–Smith America Invents Act (“AIA”), the “on sale” bar could be triggered by secret sales and offers-for-sale.


March 03, 2015
In the United States, patent term extension is available under the 1984 Drug Price Competition and Patent Restoration Act, also known as the Hatch-Waxman Act (“The Act”). The Act allows the extension of the term of a patent claiming a ...
May 21, 2012
On February 8, 2012 the The United States Patent and Trademark Office (USPTO) announced the Patents for Humanity pilot program. This 12-month program rewards patent owners for using their patented technology to address humanitarian needs by bring ...
Press Releases & Events
October 23, 2014
CHICAGO—Gary M. Ropski, a shareholder at intellectual property law firm Brinks Gilson & Lione and the firm's past president, has been named the #1 Leading Intellectual Property Lawyer in Illinois by Leading Lawyers, and fifty-nine ...
September 18, 2012
CHICAGO – Leading Lawyers Network has named 54 attorneys from Brinks Gilson & Lione, one of the largest intellectual property law firms in the United States, as 2012 Leading Lawyers in intellectual property in Illinois for 2012. The roster ...
  • Leading Intellectual Property Lawyer, Leading Lawyers Network, 2011, 2012, 2014
  • Illinois Super Lawyers, Rising Stars, 2008, 2009, 2014
  • Journal of Intellectual Property, Illinois Institute of Technology, Chicago-Kent College of Law
  • American Bar Association
  • American Intellectual Property Law Association
  • American Association for the Advancement of Science
Back to Top